SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-028920
Filing Date
2018-11-09
Accepted
2018-11-09 16:01:30
Documents
3
Period of Report
2018-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acer-8k_20181109.htm 8-K 31983
2 EX-99.1 EARNINGS RELEASE acer-ex991_6.htm EX-99.1 137267
3 GRAPHIC ghv4cft23035000001.jpg GRAPHIC 4064
  Complete submission text file 0001564590-18-028920.txt   176473
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 181173032
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1